1. Home
  2. RILYP vs SRPT Comparison

RILYP vs SRPT Comparison

Compare RILYP & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo B. Riley Financial Inc.

RILYP

B. Riley Financial Inc.

HOLD

Current Price

$5.00

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$21.28

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RILYP
SRPT
Founded
1973
1980
Country
United States
United States
Employees
2056
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.3B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
RILYP
SRPT
Price
$5.00
$21.28
Analyst Decision
Hold
Analyst Count
0
29
Target Price
N/A
$26.23
AVG Volume (30 Days)
38.1K
2.9M
Earning Date
01-01-0001
11-03-2025
Dividend Yield
7.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$854,383,000.00
$2,413,715,000.00
Revenue This Year
N/A
$13.72
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
47.15
52 Week Low
$1.73
$10.42
52 Week High
$20.00
$129.84

Technical Indicators

Market Signals
Indicator
RILYP
SRPT
Relative Strength Index (RSI) 54.23 50.54
Support Level $4.49 $21.36
Resistance Level $6.00 $22.52
Average True Range (ATR) 0.45 0.95
MACD 0.05 -0.08
Stochastic Oscillator 64.36 40.66

Price Performance

Historical Comparison
RILYP
SRPT

About RILYP B. Riley Financial Inc.

B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: